Unkila; Mikko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Unkila; Mikko.The latest application filed is for "therapeutically active estratrienthiazole derivatives as hinibitors of 17 b-hydroxysteroid dehydrogenase, type 1".

Company Profile

0.8.11

Unkila; Mikko - Turku FI
Unkila; Mikko - Piikkio FI
Unkila; Mikko - Kaarina FI
Unkila; Mikko - Littoinen FI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1 Grant 10,377,791 - Eloranta , et al. A	2019-08-13
Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1 Grant 9,850,272 - Hirvela , et al. December 26, 2	2017-12-26
Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase Grant 9,663,549 - Eloranta , et al. May 30, 2	2017-05-30
Therapeutically Active Estratrienthiazole Derivatives As Hinibitors Of 17 B-hydroxysteroid Dehydrogenase, Type 1 App 20170114090 - ELORANTA; Maire ; et al.	2017-04-27
Therapeutically Active Estratrienthiazole Derivatives As Inhibitors Of 17.beta-hydroxy-steroid Dehydrogenase, Type 1 App 20170081356 - HIRVELA; Leena ; et al.	2017-03-23
Therapeutically Active 17-nitrogen Substituted Estratreinthiazole Derivatives As Inhibitors Of 17.beta-hydroxysteroid Dehydrogenase App 20170081357 - ELORANTA; Maire ; et al.	2017-03-23
Substituted estratriene derivatives as 17BETA HSD inhibitors Grant 8,288,367 - Messinger , et al. October 16, 2	2012-10-16
Lignan formulations Grant 7,582,677 - Korte , et al. September 1, 2	2009-09-01
Lignan derivatives Grant 7,528,166 - Eklund , et al. May 5, 2	2009-05-05
Compounds and their use in therapy Grant 7,524,853 - Hirvelae , et al. April 28, 2	2009-04-28
Substituted Estratriene Derivatives As 17beta Hsd Inhibitors App 20080255075 - MESSINGER; Josef ; et al.	2008-10-16
Use of a Lignan for the Manufacture of a Composition for Preventing or Alleviating of Symptoms Relating to Estrogen Deficiency App 20080057140 - Unkila; Mikko	2008-03-06
Method of inhibiting overactivity of phagocytes or lymphocytes in an individual Grant 7,008,666 - Ahotupa , et al. March 7, 2	2006-03-07
Lignan complexes App 20050249857 - Jarvinen, Tomi ; et al.	2005-11-10
Novel compounds and their use in therapy App 20050176742 - Hirvelae, Leena ; et al.	2005-08-11
Lignan formulations App 20050169947 - Korte, Helena ; et al.	2005-08-04
Lignan derivatives App 20050101541 - Eklund, Patrik ; et al.	2005-05-12
Method for prevention of diseases in coeliac patients App 20030144216 - Unkila, Mikko	2003-07-31
Method of inhibiting overactivity of phagocytes or lymphocytes in an individual App 20030100514 - Ahotupa, Markku ; et al.	2003-05-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.